Evidence of cell kinetics as predictive factor of response to radiotherapy alone or chemoradiotherapy in patients with advanced head and neck cancer

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 1, 2000, Pages 57-63

  Corvò, Renzo ^a   Paoli, Gabriella ^a   Giaretti, Walter ^a   Sanguineti, Giuseppe ^a   Geido, Elio ^a   Benasso, Marco ^a   Margarino, Giovanni ^a   Vitale, Vito ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Cell kinetics; Chemoradiotherapy; Radiotherapy; Squamous cell carcinoma of the head and neck

Indexed keywords

BROXURIDINE; CISPLATIN; FLUOROURACIL; MAGNESIUM SULFATE; POTASSIUM CHLORIDE;

ADOLESCENT; ADULT; ADVANCED CANCER; ARTICLE; CANCER STAGING; CELL KINETICS; CLINICAL TRIAL; DNA SYNTHESIS; FLOW CYTOMETRY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; SURVIVAL TIME; THERAPY; TUMOR BIOPSY;

ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PLOIDIES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; S PHASE; TREATMENT OUTCOME;

EID: 0034177936     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00416-8     Document Type: Article

References (27)

1. Vokes E.E., Weichselbaum R.R., Lippmann S.M., et al. Head and neck cancer. N Engl J Med. 328:1993;184-194.
2. Tannock I.F. Treatment of cancer with radiation and drug. J Clin Oncol. 14:1996;3156-3174.
3. Wennerberg J. Predicting response to therapy of squamous cell carcinoma of the head and neck (review). Anticancer Res. 16:1996;2389-2396.
4. Guichard M. Comparison of the radiobiological properties of human tumor xenografts and rodent tumours. Int J Radiat Biol. 30:1989;789-793.
5. Fowler J.F., Lindstrom M.J. Loss of local control with prolongation of radiotherapy. Int J Radiat Oncol Biol Phys. 23:1992;457-467.
6. Ritter M.A. Determination of tumor kinetics Strategies for the delivery of radiotherapy and chemotherapy . Curr Opin Oncol. 2:1999;177-182.
7. Silvestrini R., Costa A., Veneroni S., et al. Comparative analysis of different approaches to investigate cell kinetics. Cell Tissue Kinet. 21:1998;123-131.
8. Wilson G.D. Flow cytometric detection of proliferation-associated antigens PCNA and Ki-67. Methods Mol Biol. 80:1998;355-363.
9. Dong H., Bertier C., Schneider E., et al. Assessment of cell proliferation by AgNOR scores and Ki-67 labeling indices and a comparison with potential doubling times. Cytometry. 28:1997;280-288.
10. Begg A.C., McNally N.J., Shrieve D.C. A method to measure the duration of the DNA synthesis and potential doubling time from a single specimen. Cytometry. 6:1985;620-626.
11. Corvò R., Giaretti W., Sanguineti G., et al. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. J Clin Oncol. 11:1995;1843-1850.
12. Wilson G.D., Pashoud N., Pavy J.J., et al. Reproducibility of measurements of potential doubling time of tumor cells in the multicentre National Cancer Protocol T92-0045. Br J Cancer. 78:1999;323-332.
13. Begg A.C., Haustermnas K., Hart A.A.M., et al. The value of pretreatment cell kinetics parameters as predictors for radiotherapy outcome in head and neck cancer A multicenter analysis . Radiother Oncol. 50:1999;1;13-1;24.
14. Zackrisson B., Gustafsson H., Stenling R., et al. Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy. Int J Radiat Oncol Biol Phys. 38:1997;677-683.
15. Miller AB, Hoorstraten B, Staquet M; et al. Reporting results of cancer treatment. Cancer 1981;47:207, 214.
16. Dolbeare F., Gratzner H.G., Pallavicini M.G., et al. Flow cytometry measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci USA. 80:1983;5537-5577.
17. Hiddemann W, Shumann J, Andreeff M. Convention on nomenclature for DNA cytometry. Cancer Genet Cytogenet 1983;134:181-183.
18. Corvò R., Giaretti W., Geido E., et al. Cell kinetics and tumor regression during radiotherapy in head and neck squamous cell carcinoma. Int J Cancer. 68:1996;151-155.
19. Merlano M., Benasso M., Corvò R., et al. Five year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst. 88:1996;583-589.
20. Sanguineti G., Corvò R., Sormani M.P., et al. Chemotherapy alternated with radiotherapy in the treatment of advanced head and neck carcinoma Predictive factors of outcome . Int J Radiat Oncol Biol Phys. 44:1999;139-147.
21. Corvò R., Sanguineti G., Scala M., et al. Primary site as predictive factor of local control in advanced head and neck tumors treated by concomitant boost accelerated radiotherapy. Tumori. 80,2:1994;135-138.
22. Kaplan E.L., Meier P. Non parametric estimation for incomplete observation. J Am Stat Assoc. 53:1985;457-481.
23. Cox D.R., Dakes D. Analysis of survival data. 1984;Chapman and Hall, London.
24. Brizel D.M., Albers M.E., Fisher S., et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 338:1998;1798-1804.
25. Corvò R., Giaretti W., Sanguineti G., et al. Chemoradiotherapy as an alternative to radiotherapy alone in fast proliferating head and neck squamous cell carcinoma. Cl Cancer Res. 3:1997;1993-1997.
26. Dishe S., Saunders M., Barret A., et al. A randomized multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 44:1997;123-136.
27. Nordsmark M., Overgaard M., Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol. 41:1996;31-39.